“ACCESS CHINA Biotech Forum @JPM Week 2022” held online from January 4th to 14th, 2022. As the largest CHINA corporate access event during the JPM WEEK in 2022, the forum had over 1000 participants from China pharma and Biotech companies. The two-week event was divided into the following sessions:
- Keynote Speeches
- China Innovation Day
- China Biotech Presentations
- Global Biotech Roadshows
- South Korea Biotech Presentations
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
Witness the Emergence of China Biotech Innovation
As of November 5th, in 2021 there has been 29 China Out-licensing and 93 in-licensing transactions have been successfully closed, representing a 20+% YOY growth. It is a symbol of the rise of China biotech innovation as a result of China’s massive investment and favorable regulatory changes. As a facilitator between China biotech innovation and the rest of the world, our forum plans to present 50+ China and 50+ global biotech companies who are looking for partnering opportunities.
We look forward to welcoming you at our Spring showcase in April!
Sincerely,
ACCESS CHINA Biotech Forum Organizing Committee
BioToChina.org 